Pulmonary cytotoxicity induced by bleomycin and methotrexate
Early detection of drug-induced pulmonary parenchymal injuries is often hampered by nonspecific clinical and X-ray manifestations. The diagnosis is usually based on a history of drug use, clinical and X-ray presentation, and exclusion of other causes of lung tissue injury.Chemical preparations most...
Saved in:
Main Authors: | Zh, V, Sheykh, A. O. Krutskevich, N. S. Drebushevskiy, S. N. Shvayko, A. P. Dunaev, V. G. Alekseev |
---|---|
Format: | Article |
Language: | English |
Published: |
Luchevaya Diagnostika, LLC
2016-03-01
|
Series: | Вестник рентгенологии и радиологии |
Subjects: | |
Online Access: | https://www.russianradiology.ru/jour/article/view/69 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
68Ga-FAPI PET/CT for diagnostic accuracy and therapeutic response assessment in bleomycin-induced pulmonary fibrosis: an integrated preclinical study
by: Rui Sun, et al.
Published: (2025-06-01) -
Efficacy and tolerability of methotrexate at a dose of 15 mg/week and 10 mg/week in patients with pulmonary sarcoidosis
by: V.K. Gavrysyuk, et al.
Published: (2021-12-01) -
Rituximab and Pirfenidone in the Treatment of Steroid‐Refractory Bleomycin Lung Injury
by: Aasir M. Suliman, et al.
Published: (2025-07-01) -
Melittin alleviates bleomycin-induced pulmonary fibrosis in vivo through regulating TGF-β1/Smad2/3 and AMPK/SIRT1/PGC-1α signaling pathways
by: Jiawang Yu, et al.
Published: (2025-04-01) -
Synthesis and In Vitro Pharmacological Evaluation of 5,8-Dideaza Analogs of Methotrexate
by: Marta Abellán-Flos, et al.
Published: (2025-06-01)